Celldex Therapeutics
Celldex develops antibody-based immunology therapies for allergic, inflammatory, and autoimmune disorders.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story
Celldex develops antibody-based immunology therapies for allergic, inflammatory, and autoimmune disorders.
November 2026
September 2026
August 2026
July 2026